Bausch + Lomb extends drop as Wells Fargo downgrades on enVista recall
Bausch + Lomb (NYSE:BLCO) stock falls as the company's voluntary recall of enVista lenses leads to a downgrade at Wells Fargo ...
Fintel on MSN6d
Wells Fargo Downgrades Bausch + Lomb (BLCO)
Fintel reports that on March 28, 2025, Wells Fargo downgraded their outlook for Bausch + Lomb (NYSE:BLCO) from Overweight to ...
Yahoo Finance6d
WF downgrades Bausch + Lomb on enVista recall giving a near-term uncertainty
Bausch + Lomb announced a recall of its enVista IOLs, including Aspire, Envy, and certain lots of monofocal lenses, due to reports of toxic anterior segment syndrome. Wells Fargo highlighted that ...
Investing6d
WF downgrades Bausch + Lomb on enVista recall giving a near-term uncertainty
Investing.com -- Wells Fargo downgraded Bausch + Lomb Corp to Equal Weight from Overweight on uncertainty from the voluntary recall of its enVista intraocular lenses (IOLs), which is expected to weigh ...
Bausch + Lomb downgraded to Equal Weight from Overweight at Wells Fargo
Wells Fargo downgraded Bausch + Lomb (BLCO) to Equal Weight from Overweight with a price target of $15, down from $24.Light Up your Portfolio ...